AdvaMed warns of gaps in product access under CMS bidding scheme
This article was originally published in Clinica
Executive Summary
US medtech industry association AdvaMed has voiced concerns over the competitive acquisition programme initiated by the Centers for Medicare and Medicaid Services (CMS). The association claims that the programme could limit the accessibility of products.